Latest papers

[Effect of phytopreparation Narcophyt on choleretic reaction in white rats with experimental hepatitis]

Multifocal granulomatous hepatitis caused by Actinobacillus pleuropneumoniae serotype 2 in slaughter pigs.

TNF pretreatment interferes with mitochondrial apoptosis in the mouse liver by A20-mediated down-regulation of Bax.

Hepatic (64)Cu excretion in Dobermanns with subclinical hepatitis.

Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.

Hepatic encephalopathy in a pregnant mare: identification of histopathological changes in the brain of a mare and fetus.

micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.

Complex roles of cyclo-oxygenase 2 in hepatitis.

Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.

A colorimetric assay method to measure acetyl-CoA synthetase activity: application to woodchuck model of hepatitis virus-induced hepatocellular carcinoma.

Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation.

Suppression of immune-mediated liver injury after vaccination with attenuated pathogenic cells.

Association of hepatitis E virus (HEV) and postweaning multisystemic wasting syndrome (PMWS) with lesions of hepatitis in pigs.

[Gene expressions of LTC4 synthase homologs in Con A-induced mouse hepatitis and regulative effect of cyclosporine A]

Diminished lifespan and acute stress-induced death in DNA-PKcs-deficient mice with limiting telomeres.

The Pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis.

Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.

Thymic stromal lymphopoietin transgenic mice develop cryoglobulinemia and hepatitis with similarities to human hepatitis C liver disease.

Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.